Brilinta - Ticagrelor 90mg Tablet

Ticagrelor belongs to a class of medications known as antiplatelet agents, which work by preventing platelets in the blood from clumping together to form clots. It is commonly prescribed following a heart attack or acute coronary syndrome, often alongside aspirin, to help reduce the risk of further cardiovascular events such as another heart attack or stroke. Ticagrelor is also frequently used after certain cardiac procedures, such as stent placement, to help keep the treated artery open and reduce the risk of clot-related complications. Unlike some other antiplatelet medications, Ticagrelor's effects are reversible, meaning platelet function typically returns to normal relatively quickly after stopping the medication. It is taken orally, usually twice daily, and consistent adherence to the prescribed schedule is important for maintaining effective protection against blood clots. Many patients are prescribed Ticagrelor for a specific duration following a cardiac event, as determined by their healthcare provider based on individual risk factors. Regular follow-up with a healthcare provider helps monitor treatment progress and address any concerns throughout the course of therapy. Many patients experience meaningful reduction in the risk of future cardiovascular events with consistent use of Ticagrelor as part of their overall heart health plan. As with all antiplatelet medications, Ticagrelor should be used under the guidance of a healthcare provider as part of a comprehensive cardiovascular care strategy.